Il rapporto
Analisi approfondite sul finanziamento aziendale, strategie di crescita e approfondimenti di mercato dalle aziende più innovative del mondo
11 report e oltre
Genentech Raises $60B in Public
Genentech, a Biotech company based in 1 DNA Way, South San Francisco, CA 94080, has raised $60B in Public at a $65B valuation led by Roche.
Genentech raises $60B Public at $65B valuation
Genentech raises $60B in Public at $65B valuation. Biotechnology company...
Genentech Headquarters - Office Location & Address
Discover Genentech's headquarters at 1 DNA Way, South San Francisco, CA 94080. Biotechnology and drug development. Learn about the office facilities and work environment.
Mayfield Fund Headquarters - Office Location & Address
Discover Mayfield Fund's headquarters at 2800 Sand Hill Rd, Menlo Park, CA 94025. Venture capital firm investing in early-stage enterprise technology and consumer companies. 50+ year history backing companies including Amgen, Genentech, Compaq, and Marketo.
Duolingo Raises $190M Secondary to Transform EdTech
Duolingo has secured $190M Secondary in funding to accelerate growth and innovation in the edtech sector. Language learning platform with 500M+ users offering gamified lessons in 40+ languages...
Coursera Raises $250M Growth to Transform EdTech
Coursera has secured $250M Growth in funding to accelerate growth and innovation in the edtech sector. Online learning platform partnering with 300+ universities and companies to offer courses, certificates, and degrees...
Brex Raises $450M Series D to Transform Fintech
Brex has secured $450M Series D in funding to accelerate growth and innovation in the fintech sector. Financial services platform offering corporate cards, banking, and spend management for startups and enterprises...
Glean Raises $260M Series D to Transform Enterprise Software
Glean has secured $260M Series D in funding to accelerate growth and innovation in the enterprise software sector. Enterprise search and knowledge management platform using AI to help employees find information across all company apps...
BioAge Therapeutics Raises $350M Series C to Transform Healthcare
BioAge Therapeutics secures $350M in Series C funding at $4.3B valuation to advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.